Osaic Holdings’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,292
| Closed | -$9.47K | – | 7610 |
|
|
2023
Q2 | $9.47K | Sell |
4,292
-1,000
| -19% | -$2.07K | ﹤0.01% | 5999 |
|
|
2023
Q1 | $13.5K | Sell |
5,292
-16
| -0.3% | -$32 | ﹤0.01% | 5801 |
|
|
2022
Q4 | $10K | Buy |
5,308
+516
| +11% | +$1.29K | ﹤0.01% | 5916 |
|
|
2022
Q3 | $13K | Hold |
4,792
| – | – | ﹤0.01% | 5894 |
|
|
2022
Q2 | $9K | Hold |
4,792
| – | – | ﹤0.01% | 6198 |
|
|
2022
Q1 | $14K | Sell |
4,792
-500
| -9% | -$1.88K | ﹤0.01% | 5957 |
|
|
2021
Q4 | $23K | Sell |
5,292
-6,018
| -53% | -$28.5K | ﹤0.01% | 5707 |
|
|
2021
Q3 | $54K | Sell |
11,310
-2,180
| -16% | -$12K | ﹤0.01% | 5048 |
|
|
2021
Q2 | $93K | Sell |
13,490
-3,330
| -20% | -$26.9K | ﹤0.01% | 4544 |
|
|
2021
Q1 | $120K | Buy |
16,820
+400
| +2% | +$2.88K | ﹤0.01% | 4205 |
|
|
2020
Q4 | $103K | Buy |
16,420
+8,590
| +110% | +$50.5K | ﹤0.01% | 4016 |
|
|
2020
Q3 | $42K | Buy |
7,830
+700
| +10% | +$3.47K | ﹤0.01% | 4438 |
|
|
2020
Q2 | $38K | Hold |
7,130
| – | – | ﹤0.01% | 4396 |
|
|
2020
Q1 | $23K | Buy |
+7,130
| New | +$26.3K | ﹤0.01% | 4547 |
|
Osaic Holdings's PRTK Position: Q3 2023 in Review
Osaic Holdings sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 4,292 shares — an estimated $9.47K sold.
Osaic Holdings first reported a position in PRTK in Q1 2020 and held it in 14 quarters. The position peaked at $120K in Q1 2021. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Osaic Holdings reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Osaic Holdings sold 4,292 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $9.47K.
- Osaic Holdings first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2020 and held it in 14 quarters.
- Osaic Holdings's Paratek Pharmaceuticals, Inc. position peaked at $120K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.